A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris

NCT02413346 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

490

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: Sarecycline

Sponsor

Almirall, S.A.

Collaborators

[object Object]